Doxt-SL Capsule (Doxycycline 100mg + Lactobacillus 5Billion Spores)

What is Doxt-SL Capsule (Doxycycline 100mg + Lactobacillus 5Billion Spores)?

Doxt-SL Capsule is a dual-action formulation containing 100mg of doxycycline, a tetracycline-class antibiotic, and 5 billion CFU of Lactobacillus probiotics. It is designed to treat a wide range of bacterial infections while helping maintain intestinal flora balance during antibiotic therapy. This combination aims to reduce the risk of antibiotic-associated diarrhea and gut microbiome disruption, commonly seen with prolonged antibiotic use.

Key features

• Antibiotic potency — 100mg doxycycline targets gram-positive and gram-negative bacteria.
• Probiotic inclusion — 5 billion Lactobacillus spores help preserve digestive health.
• Broad-spectrum use — effective against respiratory, urinary, and gastrointestinal infections.
• Supports gut balance — reduces likelihood of antibiotic-induced diarrhea.
• Oral capsule form — easy administration with consistent dosage.
• Suitable for multiple infections — including skin, STIs, and systemic bacterial conditions.
• Trusted formulation — combines established antibiotic with clinically relevant probiotic strain.

Who is Doxt-SL Capsule (Doxycycline 100mg + Lactobacillus 5Billion Spores) for?

This product is intended for adults diagnosed with bacterial infections requiring doxycycline treatment, especially those prone to digestive side effects. It may benefit individuals with a history of antibiotic-related stomach upset or those seeking to proactively support gut health during therapy. It is not suitable for children under 8, pregnant women, or individuals allergic to tetracyclines.

How does Doxt-SL Capsule (Doxycycline 100mg + Lactobacillus 5Billion Spores) compare?

Compared to standard doxycycline monotherapy, Doxt-SL offers added probiotic support, potentially reducing gastrointestinal complications. While most antibiotic regimens require separate probiotic supplements, this capsule integrates both components, improving convenience and compliance. It performs similarly to other doxycycline-based treatments in infection clearance but stands out in digestive tolerability. However, it may cost more than basic antibiotic alternatives and is not appropriate for all patient profiles.